FSRH CEU Statement : New advice from the MHRA regarding cyproterone acetate: how does this affect prescribing of Co-cyprindiol/Dianette® for acne/hirsutism? July 2020
This statement is a response to new advice from the MHRA regarding use of cyproterone acetate and risk of meningioma.
You are welcome to download our freely available Guideline documents by clicking on the document title above.
This document is up-to-date